Navigation Links
Ambry Genetics Introduces AmbryScreen(TM), a Genetic Test Screening for Some of the Most Common and Severe Genetic Disorders Affecting Newborns.
Date:5/17/2010

SAN FRANCISCO, May 17 /PRNewswire/ -- Ambry Genetics announced today at the American College of Obstetricians and Gynecologists annual clinical meeting the launch of AmbryScreen™, a genetic screening test used to identify carriers of some of the most severe and common childhood diseases affecting pan-ethnic populations.  Designed by a team of geneticists and genetic counselors with decades of clinical and laboratory experience, the panel is a responsible and ethical means of identifying individuals at high risks to have a child with severe genetic conditions.  As with all clinical assays performed by Ambry Genetics, the test must be ordered by a physician.  It is not available direct to consumer.

(Logo:  http://photos.prnewswire.com/prnh/20090428/LA06744LOGO)

The AmbryScreen™ test screens for over 90 childhood onset conditions representing only severe or common diseases. The core of the AmbryScreen™ test is the most sensitive Cystic Fibrosis carrier mutation panel in the marketplace.  It was designed by coupling the public databases of information along with Ambry's extensive database of over 25,000 patients sequenced in the last decade.  Our 100 CF mutation panel includes only well defined disease causing mutations, without containing mild CF mutations like some competing tests.  

"Ambry Genetics was founded on the idea of a comprehensive carrier test and now new technologies have enabled us to create a test that makes sense for patients and for physicians.  When we saw other companies launch seriously flawed tests, the team of Ambry genetic counselors set out to design a superior test.
'/>"/>

SOURCE Ambry Genetics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
2. Ambry Genetics Announces Launch of Their StemArray(TM) Product and Services for High Resolution Characterization of Human Stem Cells
3. Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
4. London Genetics Conference Proceedings Published in Drug Discovery Today
5. Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2010 Results
6. NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards
7. Interleukin Genetics to Raise $5.3 Million in Registered Direct Offering
8. First Awards Made by London Genetics Proof-of-Concept Fund
9. Viral Genetics CEO Issues State of the Company Update
10. Expanded London Genetics Web Site Emphasises Importance of Pharmacogenetics in Drug Development
11. Viral Genetics Files 2009 3rd Quarter Consolidated Financials and Information Statement at Pinksheets.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... , , BURLINGTON, ... of events at the Cardiovascular Research Foundation,s (CRF) annual Transcatheter ... to Friday, September 25th, in San Francisco, CA. at the ... largest events for those performing cardiac diagnostics and interventions. ...
... , ROCHESTER, Minn., Sept. 11 A Mayo Clinic ... good central nervous system repair in multiple sclerosis (MS). These findings ... with MS and for predicting MS patients, outcomes. This study will ... and Research in Multiple Sclerosis in Dusseldorf, Germany, on Sept. 11, ...
Cached Medicine Technology:InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting 2Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis 2Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis 3
(Date:4/18/2014)... Fraser University psychologists have made a brain-related discovery ... attention-deficit disorders. , This discovery opens up the ... or suppress a specific brain activity that the ... , The Journal of Neuroscience has ... John McDonald, an associate professor of psychology and ...
(Date:4/18/2014)... could lead to potential new treatments for breaking the ... , Fibrosis, or scarring, is a hallmark of the ... can lead to serious organ damage and, in some ... centers on findings made by Swati Bhattacharyya, PhD, research ... a specific protein plays in promoting fibrosis. , ...
(Date:4/17/2014)... identified the first genetic variant specifically associated with ... for around 10-15 per cent of all breast ... the breast cancer sub-type, called invasive lobular carcinoma, ... of this particular kind of breast cancer, which ... published today (Thursday) in the journal PloS ...
(Date:4/17/2014)... to a study published today in PLOS Pathogens ... where malaria is common can mount an immune response ... to avoid repeated bouts of high fever and illness ... their bloodstream. The findings may help researchers develop future ... the malaria parasite. , Each year, approximately 200 million ...
(Date:4/17/2014)... recent papers by a University of Colorado School ... develop treatments or vaccines for Dengue fever, West ... disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, associate ... School of Medicine and an early career scientist ... recently published articles in the scholarly journals ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2
... with sound advice may help them identify hearing loss ... therefore untreated. ,Hearing loss in children often remain ... and lead to deficiency in attending, difficulty in attending ... to the researcher Judith Gravel from The Children's Hospital ...
... Adjuvant chemotherapy with epirubicin and cyclophosphamide for early ... myeloid leukemia or Myelodysplastic syndrome. ,Recent study ... early breast cancer patients undergoing chemotherapy with higher ... have an increased risk of developing Acute myeloid ...
... Heidelberg in Mannheim, concludes that women appear to develop alcoholic ... that women become dependant on alcohol not as frequently as ... on the general alcohol consumption pattern if men and women. ... and before pregnancy. It might have adverse effects on the ...
... plays an important role in increasing death risk.// It is ... that can kill him. ,Depression had long been taken ... disease. Now the team of researchers from Washington University School ... rate variability is the prime cause for such a case. ...
... sterols might help to lower your "bad" LDL cholesterol ... been shown to block cholesterol's absorption, lower blood cholesterol ... intestines. , ,The study had 29 participants, all ... type 2 diabetes and were slightly overweight. Participants were ...
... popular form of ancient Indian exercise and meditation for the ... healing properties and is popularly used to relieve people of ... trauma and anxiety in patients with breast cancer., ... Yoga therapy treated over 400 patients with breast cancer with ...
Cached Medicine News:Health News:High-Dosage of Epirubicin and Cyclophosphamide may cause AML 2Health News:Yoga Can Be Good For Breast Cancer Patients 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: